BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37655078)

  • 1. Expression of DKK1 in Endometrial Endometrioid Carcinoma and Its Correlation with Wnt/β-catenin Signalling Pathway.
    Das A; Mathur SR; Kumar S; Bhatla N
    Sultan Qaboos Univ Med J; 2023 Aug; 23(3):303-310. PubMed ID: 37655078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium.
    Shaco-Levy R; Sharabi S; Benharroch D; Piura B; Sion-Vardy N
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):226-32. PubMed ID: 18295959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of beta-catenin, Glut-1, PTEN proteins in uterine endometrioid adenocarcinoma and its precursor lesions].
    Xiong Y; Xiong YY; Zhou YF
    Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):594-9. PubMed ID: 20079187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone inhibition of Wnt/beta-catenin signaling in normal endometrium and endometrial cancer.
    Wang Y; Hanifi-Moghaddam P; Hanekamp EE; Kloosterboer HJ; Franken P; Veldscholte J; van Doorn HC; Ewing PC; Kim JJ; Grootegoed JA; Burger CW; Fodde R; Blok LJ
    Clin Cancer Res; 2009 Sep; 15(18):5784-93. PubMed ID: 19737954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas.
    Moreno-Bueno G; Gamallo C; Pérez-Gallego L; de Mora JC; Suárez A; Palacios J
    Diagn Mol Pathol; 2001 Jun; 10(2):116-22. PubMed ID: 11385321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical expression of E-cadherin and beta-catenin in the normal and malignant human endometrium: an inverse correlation between E-cadherin and nuclear beta-catenin expression.
    Shih HC; Shiozawa T; Miyamoto T; Kashima H; Feng YZ; Kurai M; Konishi I
    Anticancer Res; 2004; 24(6):3843-50. PubMed ID: 15736420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype.
    Schlosshauer PW; Ellenson LH; Soslow RA
    Mod Pathol; 2002 Oct; 15(10):1032-7. PubMed ID: 12379748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MMP-2, TIMP-1, E-cadherin, and beta-catenin expression in endometrial serous carcinoma compared with low-grade endometrial endometrioid carcinoma and proliferative endometrium.
    Shaco-Levy R; Sharabi S; Piura B; Sion-Vardy N
    Acta Obstet Gynecol Scand; 2008; 87(8):868-74. PubMed ID: 18607832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and significance of beta-catenin, Glut-1 and PTEN in proliferative endometrium, endometrial intraepithelial neoplasia and endometrioid adenocarcinoma.
    Xiong Y; Xiong YY; Zhou YF
    Eur J Gynaecol Oncol; 2010; 31(2):160-4. PubMed ID: 20527231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt/Β-catenin and sex hormone signaling in endometrial homeostasis and cancer.
    Wang Y; van der Zee M; Fodde R; Blok LJ
    Oncotarget; 2010 Nov; 1(7):674-684. PubMed ID: 21317462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrium-derived mesenchymal stem cells suppress progression of endometrial cancer via the DKK1-Wnt/β-catenin signaling pathway.
    Xu Y; Hu J; Lv Q; Shi C; Qiu M; Xie L; Liu W; Yang B; Shan W; Cheng Y; Zhao B; Chen X
    Stem Cell Res Ther; 2023 Jun; 14(1):159. PubMed ID: 37287079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk of estrogen receptors and Wnt/β-catenin signaling in endometrial cancer.
    Kasoha M; Dernektsi C; Seibold A; Bohle RM; Takacs Z; Ioan-Iulian I; Solomayer EF; Juhasz-Böss I
    J Cancer Res Clin Oncol; 2020 Feb; 146(2):315-327. PubMed ID: 31865530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E-cadherin and β-catenin immunoexpression in endometrioid endometrial carcinoma.
    Florescu MM; Pirici D; Simionescu CE; Stepan AE; Mărgăritescu C; Tudorache Ş; Ciurea RN
    Rom J Morphol Embryol; 2016; 57(4):1235-1240. PubMed ID: 28174789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mouse model for endometrioid ovarian cancer arising from the distal oviduct.
    van der Horst PH; van der Zee M; Heijmans-Antonissen C; Jia Y; DeMayo FJ; Lydon JP; van Deurzen CH; Ewing PC; Burger CW; Blok LJ
    Int J Cancer; 2014 Sep; 135(5):1028-37. PubMed ID: 24474556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant expression of hypoxia-inducible factor 1α, TWIST and E-cadherin is associated with aggressive tumor phenotypes in endometrioid endometrial carcinoma.
    Feng Z; Gan H; Cai Z; Li N; Yang Z; Lu G; Chen J
    Jpn J Clin Oncol; 2013 Apr; 43(4):396-403. PubMed ID: 23372184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical and genetic profiles of endometrioid endometrial carcinoma arising from atrophic endometrium.
    Geels YP; van der Putten LJ; van Tilborg AA; Lurkin I; Zwarthoff EC; Pijnenborg JM; van den Berg-van Erp SH; Snijders MP; Bulten J; Visscher DW; Dowdy SC; Massuger LF
    Gynecol Oncol; 2015 May; 137(2):245-51. PubMed ID: 25773202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOX17, β-catenin and CyclinD1 expression in the endometrioid adenocarcinoma and influence of 5-AZA on expression.
    Liao YM; Song Y; Li YK; Du JH; Zhou Y
    Cancer Gene Ther; 2020 Apr; 27(3-4):256-263. PubMed ID: 31543512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel expression profiles and invasiveness-related biology function of DKK1 in endometrial carcinoma.
    Yi N; Liao QP; Li T; Xiong Y
    Oncol Rep; 2009 Jun; 21(6):1421-7. PubMed ID: 19424619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromal Clues in Endometrial Carcinoma: Loss of Expression of β-Catenin, Epithelial-Mesenchymal Transition Regulators, and Estrogen-Progesterone Receptor.
    Senol S; Sayar I; Ceyran AB; Ibiloglu I; Akalin I; Firat U; Kosemetin D; Engin Zerk P; Aydin A
    Int J Gynecol Pathol; 2016 May; 35(3):238-48. PubMed ID: 26367784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
    Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.